, , ,

<<


-  >> 
Pages:   || 2 | 3 | 4 | 5 |   ...   | 12 |
-- [ 1 ] --

XIV- -

XXI

01 03 2013 1 371 74.58 56 XXI : XIV- 01 03 2013 . / . .. , .. , .. : , 2013. 432 .

, .

, , . , , , , , , , .

ISBN 978-5-4338-0100- , , , ISBN 978-5-4338-0100- , !

XIV- XXI .

- , .

, , , .





. , .

, , .

: , , , , , , , , , , .

, , , , .

, , !

, , , , .. !

XIV - XXI .

, . , . next , , .

IV- - XXI c 17 : , , , , , , , , , , , , , , , , .

, , - , , , IV - XXI . , , .



, , .. 1. .. C- .................................................................................................... 2. , .., .. ...................... .., .., ., .., .., . .................................................. . . ............................... . - ().................................................................................... .., . ............................................................................................... . - ...................................................................................................... 3. .., .., .., .., . ...................................... .. .................................................................................... .. .................................................................................................... ., .. , ........................................................................... . ., .. ....................................................................... . ., . ., .. ... .. ................. .., .., .. , ......................... .., .., .. ... .., .. .................. .. .. ҅...................................................................... ., . . ...................................................... .., .. ...................... . . , .............................................................................................. .. - ......... . ... .., .. ...................................................................................................................... .., . ............................................................................................... . . ........................................................................ . ., .. ....... .. ........................................................................................ 4. .., . . ......................................................... .., . ................................................................................... . ., . . - ............................................................ . ............. .., .. ........................... . ., . ., . ., ..

..................................... .., .. ............................................................................... .., .., .., ..

........................................................................................ .., .., .. ................................................................ .. .................................................... .., .., .., ..

III ............................................................................ .. ................................. .. HCV .............................................................. 5. .., .. II .......................................... .., .., .., ..

2................................... .., .. 1 6 C ................. .., .. ....................................................................................... .., .. ..... .., .. ............................................................................................ .., .., .., ..

........................................................................... . ................................................................................................................... . ., .. 10 .................................................. .., .., . ...................................................................... . ............................................................... . ............................................................................................... .., .. ................... .., .., ..

................................... .., .. ........................................................... 6. . , ................................................................................................................ . . , ....................................................................................... .., .., .. ........................... .. .......................................................... . . ................ .. ........................................................................ .., .., .., .., ..

........................................................................................... .., .. - Ļ

......................... ., ., .. .................................................................... .., .., .. , ................................................................................. .., .., .., ..

............................................................... 7. . ., . ., . ., . .

................................................................................................ .., .., .. .......................................................................................... .., .. ............................... .., .. ............................. 8. .

.., .., .. .......................................... .., .., ..

?...................................... .. ............................................................................................................... .., .. , ....................... .., .. .......................................................................... .. . ..................................... .., .. ................................................................................... . ..................................................................................... 9. .., .. .................................................................................... .., .. ....................................................

.......... .., .. .................................................................... .. .................................................................. .., .. ..................................................................................................... 10. .., .. : ..... .. ............................................................................... .., .. .................. .. ....................................................................................... .., .. ....... . , ................................................................ . .................................... .. ....................... 11. . . .............................................................. .. .................................................................................... .., .. ....................................................... .. II III ................................ .., .. .. .. .............................................................................. . ....................................................................................... .. ........................................................... .., .. ................................................... .. ........................................................................ .. ................................................................................ .. - .......................................................... .. .......................................................................... .. ........................................................................................................ .. .................................................... .. ........................................................................ .. Ҩ ............................................................ ., . ........................................................................ .. ........................... .. ................................. .. ............................................................................................. 12. .., .. ................................................................................... .., .., .. :

-».............. . . ............................................................................................................ .. ......... .. . ..................................................................... .., .. .............................................................. .. . . ........... .., .., .. Ҩ ....... .., .. ................................................................ .. . ....................................................... .., .. - ................................... .., .. ....................................... .., .., .., ..

............................................................................ .M. .............................................. .. ........ .. ................................................ .. ................................................ .., .. ............... .. 3169 . ˨....................................................... .. ................................................. .. ............... . . ... . ., . . ................................................................ . ., . ., .. Ȼ.............................. Schmakowa L.W. DIE BEHANDLUNG DER AKUTEN EMPFINDLICH NEURALEN SCHWERHRIGKEIT MIT HILFE DER METHODE DER INTRATYMPANALEN DER EINFHRUNG DER ARzNEIMITTEL TREATMENT FOR ACUTE SENSORIONEURAL HEARING LOSS WITH INTRATYMPANIC DRUG INFUSION............................................ Anisimova S.G., Sitnikova E.I. DIE EINWIRKUNG DES ENERGIEPROTEKTORS CYTOFLAVINS IN DER KOMPLEX BEHANDLUNG BEI DEN SCHWEIER UND BUCHHALTER MIT DEM SYNDROM DES TROCKENEN AUGES........................................ Shilokhvostova D.S., Imbryakov K.V. HISTORICAL EVIDENCES OF FAMOUS PEOPLES FACIAL FURUNCLES AND CARBUNCLES.................................... 13. .., .. ...................................................................................................... .., .. ܻ ................................ .., .. .................................................... .., .., .. .................................................................. .. ..................................................................... .. .............................................................. .. , .................................................................................. .

. - , .............................................. .., .. 3-5 160 . ............................. .., .. .................................................. .. ................................................................................... .., .. . ........................................................................ 14. .. ˨ ................................................................................................. 15. .. -2 ....................................................................................................... . ., . . ............................................................................... .., .., .. .................................................................................. .., .. ............................................. ., ., . , ....................................................................................... .., .., .., ..

...................................... .., .. -.......................................................... .. - - ............................ .., .., .. ........ . ., . . .......................................... .., .. 15.9 - .................................................................................. .., .. ................................................................................. .. -...................................................................................... .. .. ................ .., .. ................................................................ .., .., .. λ -..... .. .................. .. ............................................................. .. ............... .., .. .................................................................................. .., .. , ......................................................................... . , ()............................................................... .. - ().................................................................................... . . 2 ................................................................................................. . . , .......................... .. - ........... . ., . . ......................................................................................................................... .. ................................................................................... .., .. ..... .., .. ................................................................................................... .., .. .................................................................. .. ............................................................................................ .., .. .

........................................................................ .., . . . ................................................................................................. 16. .., .. .................................................................................................... .. ................................................................................... .., .. 50 ........................ .. ˨ ˨............. .. ................................................... .., .. ................................................................................... .., .. ˨ ............................................... .. ...................................... .. ..... .. - ................................................................................ 17. , .., .., .. ......................................................................................................... .. ... .., .. ............. .., .., ., ..

........................................................... .. ............................................................ .., . , .................................. 1. C- ..

. : . .. : . .. PCIHO-EMOTIONAL STATE OF PREGNANT WOMEN WITH CHRONIC HYPERTENSION Dzhalilova V.D.

Kirov State Medical Academy Department of Obstetrics and Gynecology HADS . , , .

: - .

:

1) - ;

2) .

. HADS20 2012 . 14 , , 0 () 3 ( ). : - - .

, : 0-7 - ( ), 8-10 - , 11 - .

31,115 .

0-7 9 (45%) , 4,67 3. 8-11 7 (35%) , 8,861. 11 4 (20%), -12,251.

0-7 15 (75%) , 4,43. 8-10 5 (25%) , 8,61. 11 .

. 20 , .

.

2. , .., ..

. : . .. : . .. Ultrastructure of the testes and epithelial reticular cells of thymus of white rats after inhalation exposure to epichlorohydrin Voloshina I.S., Voloshin V.N.

Lugansk State Medical University Human Anatomy Department . . , , , , (, , .). , , .

24 - 130-150 . . , , (, 1985). .

. (I) , 10 / 60 (5 / 5 ). , , , , . ( 6 ) (1 30 ). , . 1 3. 24 , 1% 1 . , , . 600. - (), -125 .

. , , . , , , . , 1 , . , , . , , . , , . - . 30 4 - . .

, , . , -, .

, , 1 30 .

1 I , . .

, , , . , . - . . , , , , . . 30 , 1 , .

I .

, , ;

;

. - .

.., ..

., .., .., ..

, , : . .. , . .. ABOUT THE INFLUENCE OF THYMOKESIS ON YOUNG CHILDRENS DE VELOPMENT V.L.Sykova, T.G.Torkunova, M.A. Tyurina M.A. Raush, M.A. Yevlyukhina, E.


A. Dakadova Kirov StateMedical Academy Department of Family Medicine the Institute of Postgraduate Education, Department of Histology, Embriology and Cytology . . -, . . , - -. . - -. . - , , , 10-13% . . : . : 1) ;

2) - - ;

3) . : 520 . : 15 , (5 33,3%) ( ), 10 (66,7%) . (10 - 66,7%), (5 - 33,3%). 4,5 12 . 60% , 40% . , 100% . ( ). 9750 . (12 80%), (2 13,3%) (1 6,7%) . , 1 3 , . - 5 (33,3%) - . 4,1 . 2 60% , 7,3 .

(10 66,7%) (), 1 (9 - 90%) 2 (1 - 10%). , 5 , (16,5%). 60% (9 ), (33,3%), 6 (66,7%). 0-1 6 2,3 . . , , , , , , , , , . , .

. .

. : . . . , . . : . . . : . . GENE EXPRESSION OF ANDROGEN RECEPTOR AND ENzYMES METABO LIzING ANDROGENS IN PROSTATE TUMOR TISSUE Korbut A. I.

Novosibirsk State University Department of Fundamental Medicine Institute of Molecular Biology and Biophysics of Siberian Branch of the Russian Academy of Medical Sciences, Novosibirsk Department of Molecular Mechanisms of Carcinogenesis () . 1560 % 40 80 % 80 . (). , .

() (AR) in situ. . , .

(HSD3B1, HSD17B3, SRD5A2, AKR1C3) (HSD17B2, AKR1C2, -3, UGT2B17) AR .

(N=14) (N=6). .

- . . . GAPDH ( -, ).

:

1. HSD17B3 1,3 , SRD5A2 1,5 , HSD17B2 6 , AKR1C2 4 (p0,05 ).

AR 2.

2 , HSD17B3 1,7 , SRD5A2 2,5 , HSD3B1 2 HSD17B2 4 (p0, ).

3. HSD3B1 2 (p=0,0005) SRD5A2 6 (p=0,0012) .

4. AR 1,5 (p=0,003) HSD17B3 2 (p=0,02) .

5. : ARHSD17B3, ARSRD5A2, ARHSD17B2, HSD17B3SRD5A2 ., .

AR (HSD17B3, SRD5A2, HSD3B1), HSD17B2 (). HSD17B3, SRD5A2, HSD17B2, AKR1C2, , . AR SRD5A2 , .

.

12-04-31587 _.

- () . . : . . : . .. REGULATION OF THE SODIUM REABSORBTION IN THE RATS WITH INHERITED STRESS-INDUCED ARTERIAL HYPERTENSION (ISIAH) Nizomov S.A.


Novosibirsk State University, Medical Faculty, Department of Fundamental Medicine Institute of Cytology and Genetics SB RAS . 30%. 95% .

, , , . Na+ , . , Na+ , , , , Na+. . ( ), .

, , .

:

1) 5 % ;

2) (2%) 5% ;

3) 5% ;

, , , , , .

. - 5% , , . (, , , , ). : , ;

, , . (, , , , ).

. , , WAG. . , . , , .

. , , SHR.

, -- . , , .

.., ..

. : . .. : ... .. .., . .. CONSTRUCTION OF THE SPLEENLYMPHOID STRUCTURES IN EXPERI MENTAL ACUTE DESTRUCTIVE PANCREATITIS Shirshov A.A, Izergina K.V.

Kirov State Medical Academy Department of General Surgery , , , , , .

, , . .

. ;

.

. [3] 30 180220 . .

. 1 .

1 1, 3, 7, 14- , ( 5 ) , , , . , : (), .

Biostatistica 0,05.

. (- ), , 0,0090,006 ( ) 0,0140,005. 23,66,6 ( ) 115,629,5.

51,23,0 (0,05), 0,0540,01 .

, . 0,063 0,01. 101,024,6, , (0,05).

(109,817,4), - 0,0660,009 .

0,0550,006 , , 88,610,1 (0,05).

- , .

( 1- 7 ). .

- ..

. : . .. : ... .. . : . .. : . .. STRUCTURAL AND FUNCTIONAL CHANGES OF PANCREAS IN ACUTE DE STRUCTIVE PANCREATITIS Simonov D.V.

Kirov State Medical Academy Department of General Surgery, Vyatka State Agricultural Academy Department of Morphology and Microbiology . . 6 26%, 50-85% . , , , .

, . , .

. .

. ( .., 1985) 40 180220 .

. 1 .

, 1, 3, 7, 14- , , JEM-100C. ImageScope Color . , ( , - ), Biostatistica 0,05.

. , . 181,811,76 , (167,1310,94 ). , - . 194,189,66 ;

7 184,11,9 , . 14 (186,04,9 ).

. : 1 ( 1014 11,2 ), (89123,1 ), . 7 (981 64,6 ), , 14 837,6 51,5 .

- . 19,141,5 ( -16,80,01), - , - .

23,51,3 . 7 - (21,141,2), -, . 14 (24,71,2), .

, , . , , -, . 7 , .

14 - , .

3. .., .., .., .., ..

. : . .. : . .. EFFECTS OF MMSC ON VARIATION OF LIVER HYDROXYPROLINE IN CHRONIC TOXIC HEPATITIS Vazhenina M.S., Osipov A.V., Marchenkov A.A., Seleznev M.K., Sergeeva L.G.

Kirov State Medical Academy Department of biology . , , , . , ( .., 2009). , , . , . () .

. ().

:

1) ;

2) ;

3) ;

4) .

. . () 66% (CCl4) 0,2 100 .

, 20 . zuc - 10% (zuc, 2003). CCl4 1 . . 15 . : 1 , 2 , 3 , 4 +. . Bergman, Loxely (1970) .. (1976). .

. 4,520,69 /., 2,770,05%. 3,870,53 /, . (=0,01) 4,350,16%. , . , ., , . 5,491,84 /, . 4,250,24%, . 3,630,18 /. 4,730,23%.

, . , .

..

. : . .. : . .. VISUALIzATION OF REACTION OF HYDROCINDERY AGGLUTINATION Valitova R.R.



Pages:   || 2 | 3 | 4 | 5 |   ...   | 12 |
 
-  >> 



:





 
<<     |    
2013 www.libed.ru - -

, .
, , , , 1-2 .